Skip To Content
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.
Learn More
1093:HKHong Kong

CSPC Pharmaceutical Group Ltd

COMPANY INFO
13.78HKD
-0.08-0.58%
Market Open
As of 10:41 PM EDT 05/20/2019 EDT
Open
13.86
Prev Close
13.86
Volume
3,932,420
Market Cap
86.436B
Day Range
13.6413.96
52 Week Range
9.9026.75
1D1M1Y5Y
View Full Chart
Market Open
As of 10:41 PM EDT 05/20/2019 EDT
1D1M1Y5Y
View Full Chart
markets
Don’t See a Lot of Risk Premium Across Many Asset Classes, Says Conning’s Yeo
Before it's here, it's on the Bloomberg Terminal.
Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

Key Statistics

P/E Ratio23.67
Bloomberg (BEst) P/E Ratio19.1389
Bloomberg (BEst) PEG Ratio1.2028
Shares Outstanding6.24B
Price to Book Ratio5.0168
Price to Sales Ratio4.0904
1 Year Return-41.74%
30 Day Avg Volume31,195,700
EPS0.59
Bloomberg (BEst) EPS Curr Yr0.7220
Dividend1.32%
Last Dividend Reported0.18
Earnings Announcement for Period Ending Q2/2019:05/21/2019

Compare
1-Day Performance

-1%0
-1%0
Equity
1093:HK
-0.58%
Sponsored By

About CSPC Pharmaceutical Group Ltd

CSPC Pharmaceutical Group Limited, through its subsidiaries, manufactures and sells pharmaceutical products. The Company's products include vitamin C, antibiotics and common generic drugs. The Company is also engages in the development of innovative drugs and antibiotics.
Address
226 Huanghe Road Qiaoxi District Shijiazhuang, 050035 China
Phone
86-311-8703-7015
Website
www.e-cspc.com

Income Statement

Quarterly
Annual
;
Q4 2018 (Millions HKD)
  • Revenue
    5,180.1
  • Net Income
    921.1
  • Profit Margin
    17.78%

Balance Sheet

Quarterly
Annual
;
Q4 2018 (Billions HKD)
  • Total Assets
    26.0
  • Total Liabilities
    9.0
  • Debt to Assets
    7.43%

Cash Flow

Quarterly
Annual
Sorry, no quarterly data is available at this time.
Q2 2019 (Millions HKD)
  • Operating
    --
  • Investing
    --
  • Financing
    --